Document is current
Any future updates will be listed below
-
Authors
Robbertz, Abigail S. https://orcid.org/0000-0002-1074-7787
Weiss, David M.
Awan, Farrukh T.
Byrd, John C.
Rogers, Kerry A.
Woyach, Jennifer A.
-
Funding
Funding for this research was provided by:
Pelotonia
Morphosys
AbbVie Biotherapeutics
Karyopharm Therapeutics
Pharmacyclics
Janssen
Acerta
AstraZeneca
Sunesis
Innate Pharma
Genetech
Gilead
Acerta Pharma
- License Information
-
More Information
Article History
Received: 17 January 2019
Accepted: 11 July 2019
First Online: 22 July 2019
Compliance with ethical standards
:
: Abigail S. Robbertz has no COI. Dave M. Weiss received funding from Pelatonia. Dr. Farrukh T. Awan received funding from AbbVie, Pharmacyclics, Janssen, AstraZeneca, Sunesis, Innate Pharma, Genetech, and Gilead. Dr. John C. Byrd has no COI. Dr. Kerry A. Rogers received funding from Genetech and Acerta. Dr. Jennifer A. Woyach received funding from Morphosys, AbbVie, Karyopharm, Pharmacyclics, Janssen, and Acerta.
